Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7401 p586
20 May 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Predictable recovery of fertility after male hormonal contraception

Hormonal male contraception regimens are reversible within four to five months, according to the authors of a paper published in The Lancet (2006;367:1412).

The researchers analysed 30 studies in which 1,549 men aged 18–51 years were treated with an androgen or androgen-progestogen regimen for at least three months. The primary endpoint was time to recovery of a sperm concentration of 20 million per ml, an indicator of fertility. They found that rates of recovery were lower with longer treatment, non-Asian ethnic origin or with use of long-acting preparations. Recovery rates were higher with older age, faster suppression of spermatogenesis, lower blood concentrations of luteinising hormone at baseline and higher baseline sperm concentrations. However, the reseachers note that these factors are quantitatively unimportant.

They calculate that the median time of recovery for a hypothetical 35-year-old white man given testosterone undecanoate for one year would be 4.6 months. If the man was Asian it would be 4.1 months. A total of 90 per cent of individuals can expect to recover fertility within 12 months, and all individuals can expect to recover within 24 months, they say.

“Our data provide strong assurance that the previously described efficacy of hormonal male contraceptives is coupled with highly predictable recovery to semen characteristics that are compatible with fertility,” they conclude.

Back to Top


©The Pharmaceutical Journal